Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency

Lin Cheng; Yajuan Liu; Wenjing Wang; J. L. Merritt; Matthew Yeh

doi:10.1155/2019/2313791

Case Reports in Hepatology (Jan 2019)

Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency

Lin Cheng,
Yajuan Liu,
Wenjing Wang,
J. L. Merritt,
Matthew Yeh

Affiliations

Lin Cheng: Department of Pathology, Rush University Medical Center, Chicago, IL, USA
Yajuan Liu: Department of Pathology, University of Washington, Seattle, WA, USA
Wenjing Wang: Department of Pathology, University of Washington, Seattle, WA, USA
J. L. Merritt: Department of Pediatrics, University of Washington, Seattle, WA, USA
Matthew Yeh: Department of Pathology, University of Washington, Seattle, WA, USA

DOI: https://doi.org/10.1155/2019/2313791
Journal volume & issue: Vol. 2019

Abstract

Read online

Ornithine transcarbamylase (OTC) deficiency is an X-linked recessive disorder that leads to hyperammonemia and liver damage. Hepatocellular adenoma in OTC deficiency patients has not been previously described. Here we report the first such case to be described in the English language scientific literature.

Published in Case Reports in Hepatology

ISSN: 2090-6587 (Print); 2090-6595 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: https://onlinelibrary.wiley.com/journal/8571

About the journal